CBN (cannabinol) is a mildly active compound found in cannabis that is primarily marketed as a sleep aid, though its effects extend to pain modulation and potential brain cell protection. Unlike THC, CBN is classified as non-psychoactive, meaning it won’t produce a high. Most people encounter it in supplement form, often as gummies or tinctures sold for sleep support.
How CBN Affects Sleep
The most common reason people take CBN is to fall asleep faster or stay asleep longer, and there is growing evidence to support this use. In a 2024 study published in Neuropsychopharmacology, researchers measured CBN’s effects on sleep architecture using brain-wave monitoring in rats. CBN increased total sleep time by a magnitude comparable to zolpidem (the active ingredient in Ambien), boosting both deep sleep and REM sleep. Zolpidem, by contrast, only increased deep sleep without affecting REM. One interesting wrinkle: CBN showed a biphasic pattern, briefly suppressing sleep before triggering a dramatic increase. So if you take CBN and don’t feel sleepy right away, that initial delay may be part of how the compound works.
The researchers also discovered that a metabolite your body creates when it processes CBN (called 11-hydroxy-CBN) has its own sleep-promoting effects, which may explain why CBN’s influence on sleep can feel prolonged.
Despite these promising animal results, rigorous human clinical trials are still catching up. A major trial called the CUPID study is testing single oral doses of 30 mg and 300 mg CBN in people with diagnosed insomnia, measuring both sleep quality and next-day functioning. Most commercial CBN products contain somewhere in the range of 5 to 25 mg per serving, which sits at or below the lower end of what clinical researchers are testing. Earlier human studies that combined small doses of CBN (2 to 5 mg) with THC did show improved subjective sleep, but those results are hard to separate from THC’s own sedating effects.
It Won’t Get You High
CBN is consistently classified as a non-psychoactive cannabinoid. While it does bind to the same receptors in the brain that THC targets, its affinity is much weaker. In a controlled 1975 study, volunteers who took 50 mg of CBN alone reported no significant difference from placebo in feeling “drugged, drunk, dizzy, or drowsy.” Only when CBN was combined with THC did those sensations increase. A later study in 1987 gave volunteers 20 mg of CBN intravenously and through inhalation, with researchers noting “no psychoactive effects” from either method. So at the doses found in commercial products, CBN on its own should not produce any intoxicating feeling.
Pain and Inflammation
CBN interacts with several receptor systems involved in pain signaling, including TRP channels (the same receptors that detect heat from chili peppers) and receptors that regulate inflammation. Through these pathways, CBN can reduce the activity of inflammatory molecules and scavenge harmful oxygen compounds that damage cells. This gives it both anti-inflammatory and antioxidant properties, at least in laboratory settings. Some people use CBN topicals for localized muscle or joint discomfort, though human clinical data specifically on CBN for pain remains limited compared to CBD or THC.
Potential Brain-Protective Effects
Research from the Salk Institute has shown that CBN protects brain cells by preventing dysfunction in mitochondria, the energy-producing structures inside neurons. When mitochondria fail, neurons die through a process called oxytosis/ferroptosis. CBN appears to interrupt this chain of events. In 2024, Salk researchers went further by engineering four CBN-inspired compounds that were even more neuroprotective than CBN itself. One of those compounds produced the highest survival rate in a fruit fly model of traumatic brain injury. These findings point toward potential applications for conditions like Alzheimer’s, Parkinson’s, and traumatic brain injury, though no human trials for neuroprotection have been completed yet.
Side Effects and Safety
CBN appears to be well tolerated based on the limited human data available. In early studies where volunteers received CBN alone (up to 50 mg orally or 20 mg intravenously), no one reported significant adverse effects. In one study, participants were encouraged to take as much CBN as they could “comfortably tolerate,” and none asked for administration to stop. They described the experience as “mild and enjoyable.” The most commonly reported effect is drowsiness, which is more of an intended outcome than a side effect for most users.
One area that deserves attention is drug interactions. CBN inhibits several liver enzymes responsible for breaking down a wide range of medications. It blocks enzymes that process common anti-inflammatory drugs, blood thinners, antiepileptics, certain antidepressants (including bupropion), and blood pressure medications. If you take prescription medications in any of these categories, CBN could slow their metabolism and effectively increase their concentration in your body. This is a meaningful concern that most CBN product labels don’t mention.
Legal Status
CBN derived from hemp (cannabis containing less than 0.3% THC) is technically legal at the federal level under the 2018 Farm Bill. However, the FDA has not approved CBN as a dietary supplement or food additive, and the regulatory landscape for hemp-derived cannabinoids remains unsettled. Some states have enacted their own restrictions on cannabinoid products, so legality varies depending on where you live. CBN products are widely sold online and in retail stores, but they exist in a regulatory gray area where quality control and labeling accuracy are not consistently enforced.